To include your compound in the COVID-19 Resource Center, submit it here.

NGX426: Phase I data

In a double-blind Phase I trial in 18 healthy volunteers, 150 mg of

Read the full 134 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE